Full text is available at the source.
Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists
How Glucagon-Like Peptide-1 Receptor Agonists May Reduce Artery Plaque: Direct or Indirect Actions?
AI simplified
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce major adverse cardiovascular events in patients with and without Type 2 diabetes.
- GLP-1 RAs are associated with improvements in lipid metabolism, insulin sensitivity, and blood pressure.
- Direct vascular actions of GLP-1 RAs may include anti-inflammatory effects and suppression of oxidative stress.
- These agents could improve endothelial function and modulate the behavior of immune cells in the vasculature.
- GLP-1 RAs may inhibit the proliferation and migration of vascular smooth muscle cells.
- The mechanisms underlying these effects are mostly derived from preclinical or animal studies, indicating a need for further research in humans.
AI simplified